CN112316101A - Baicao suction moxibustion for relieving stroke sequela and preparation method thereof - Google Patents
Baicao suction moxibustion for relieving stroke sequela and preparation method thereof Download PDFInfo
- Publication number
- CN112316101A CN112316101A CN202011418153.XA CN202011418153A CN112316101A CN 112316101 A CN112316101 A CN 112316101A CN 202011418153 A CN202011418153 A CN 202011418153A CN 112316101 A CN112316101 A CN 112316101A
- Authority
- CN
- China
- Prior art keywords
- parts
- moxibustion
- relieving
- preparation
- baicao
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
- A61K36/8884—Arisaema, e.g. Jack in the pulpit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H39/00—Devices for locating or stimulating specific reflex points of the body for physical therapy, e.g. acupuncture
- A61H39/06—Devices for heating or cooling such points within cell-life limits
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/55—Glands not provided for in groups A61K35/22 - A61K35/545, e.g. thyroids, parathyroids or pineal glands
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/237—Notopterygium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/24—Apocynaceae (Dogbane family), e.g. plumeria or periwinkle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/51—Gentianaceae (Gentian family)
- A61K36/515—Gentiana
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/69—Polygalaceae (Milkwort family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/716—Clematis (leather flower)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/718—Coptis (goldthread)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8962—Allium, e.g. garden onion, leek, garlic or chives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8988—Gastrodia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/10—Expectorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/15—Preparation or pretreatment of starting material involving mechanical treatment, e.g. chopping up, cutting or grinding
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Alternative & Traditional Medicine (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Pulmonology (AREA)
- Zoology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Cell Biology (AREA)
- Rehabilitation Therapy (AREA)
- Virology (AREA)
- Developmental Biology & Embryology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Physical Education & Sports Medicine (AREA)
Abstract
The invention discloses a herbal moxibustion for relieving apoplexy sequelae, which is prepared from arisaema cum bile, abalone shell, poria cocos, coptis chinensis, polygala tenuifolia, notopterygium root, uncaria, Chinese starjasmine stem, safflower, large-leaved gentian, clematis root, old shallot, fresh ginger, beautiful sweetgum fruit, deer sinew, musk, gastrodia tuber powder, hemp seed oil and peach seed oil. The herbal moxibustion is mainly used for treating symptoms such as restlessness, insomnia, excessive and white phlegm, language disorder, yin deficiency and essence deficiency, constipation due to fu-organs, urinary incontinence, limb stiffness and pain, aphonia, deficiency of middle-jiao, yin deficiency, hemiplegia, foot swelling, high blood pressure and the like, has the effects of tonifying qi, activating blood, removing stasis, reducing phlegm, tonifying spleen, dredging collaterals and the like, and has the characteristics of good curative effect, quick radical cure and the like.
Description
Technical Field
The invention belongs to the technical field of traditional Chinese medicine production and processing, and particularly relates to a Baicao moxibustion for relieving apoplexy sequelae and a preparation method thereof.
Background
Apoplexy is also called stroke or cerebrovascular accident, and is mainly caused by sudden syncope, unconsciousness, facial distortion, hemiplegia and language disorder, and mild patients may feel coma, while hemiplegia and facial distortion are mainly caused. Apoplexy is a common disease and frequently-occurring disease of middle-aged and old people, is a common disease of clinical internal medicine taking cerebral ischemia and hemorrhagic injury symptoms as main clinical internal medicine symptoms, is one of three diseases which have the greatest harm to human beings in the world at present, and has the characteristics of high morbidity, high mortality, high disability rate, high recurrence rate and more complications, namely 'four-high one-high'. Relevant survey data indicate that the incidence rate of stroke in China is about 700 or more than ten thousand people per year, wherein about 120/10 people are dead, and about 70% of the living patients have disability, so that the daily life, work and life quality of the patients are adversely affected.
Although the patients with apoplexy are treated actively, sequelae, namely apoplexy sequelae or cerebral apoplexy sequelae, still exist in most of the patients with apoplexy. The cerebral apoplexy sequela is a disease of sequela of different degrees of dyskinesia, cognitive disorder, speech dysphagia and the like of hemiplegia, numbness, deviation of eyes and mouth, watery mouth, sallow complexion, speech disorder and the like which are left in most patients after acute cerebrovascular disease is caused. Stroke is commonly called stroke, is the disease name in traditional Chinese medicine, has high mortality rate in the early stage of hemorrhagic stroke, about half of patients die within several days of disease, most survivors have sequelae and the like. The ischemic stroke patient clinically takes hemiplegia as a main sequela. If the treatment is not performed earlier, the limbs gradually become spasm and stiffness, causing disuse stiffness and contracture of the limbs, resulting in deformity and loss of function of the limbs. Patients who have suffered from the cerebral apoplexy are easy to relapse, and the cerebral apoplexy is aggravated once every relapse, so that the improvement of the prevention and treatment level of the cerebral apoplexy, the reduction of the incidence rate and the disability rate of the cerebral apoplexy, and the enhancement of the treatment and the conditioning of the cerebral apoplexy sequelae are urgent.
At present, there are some published documents about traditional Chinese medicines for relieving sequela of stroke, for example:
1. the patent application CN201711132333.X discloses a traditional Chinese medicine composition for relieving sequela of apoplexy, belongs to the field of pharmacy, and the traditional Chinese medicine composition for relieving sequela of apoplexy provided by the invention comprises the following raw materials: raw astragalus membranaceus, prepared rehmannia root, Chinese angelica, red paeony root, ligusticum wallichii, peach kernel, safflower, periostracum cicadae, earthworm, stiff silkworm, rhizoma acori graminei, scorpion, centipede, salvia miltiorrhiza, cowherb seed, tangerine pith and liquorice. The traditional Chinese medicine composition provided by the invention is specifically classified for the apoplexy sequelae, starts from the functions in vivo, promotes blood circulation to remove blood stasis, searches for wind and dredges collaterals, and has good curative effect on relieving the apoplexy sequelae.
2. Patent application CN201510949478.3 discloses a traditional Chinese medicine for treating liver-yang hyperactivity type apoplexy sequelae, which is prepared from the following raw materials in parts by weight: 30-40 parts of ophiopogon latifolius, 30-40 parts of dog ant grass, 20-30 parts of concha haliotidis, 20-30 parts of Chinese chestnut mistletoe, 20-30 parts of akebia stem, 20-30 parts of ginseng, 10-15 parts of gynura divaricata, 10-15 parts of small milkwort, 10-15 parts of henbane, 10-15 parts of bovine horn pseudo-ginseng, 10-15 parts of yellow goat horn, 5-10 parts of herb of common lopseed, 5-10 parts of snow mountain liquorice, 1-5 parts of shiitake mushroom and 1-5 parts of trichosanthes peel. The invention adopts pure Chinese medicinal preparation, the selection of the medicinal materials in the formula accords with the principle of monarch, minister, assistant and guide, the proportion of the formula has synergistic effect, and the curative effect can be obviously improved. The traditional Chinese medicine disclosed by the invention can promote blood circulation, remove meridian obstruction, nourish blood, tranquilize mind, effectively relieve symptoms such as headache, dizziness, bitter taste and the like caused by stroke, promote blood circulation, improve organism immunity and repair functions, has good treatment and regulation effects on the liver-yang hyperactivity type stroke sequela, treats both symptoms and root causes, and has small side effect.
3. The patent application CN201510803364.8 discloses a traditional Chinese medicine composition for relieving sequela of apoplexy, which belongs to the field of pharmacy and is composed of the following raw materials: raw astragalus membranaceus, prepared rehmannia root, Chinese angelica, red paeony root, ligusticum wallichii, peach kernel, safflower, periostracum cicadae, earthworm, stiff silkworm, rhizoma acori graminei, scorpion, centipede, salvia miltiorrhiza, cowherb seed, tangerine pith and liquorice. The traditional Chinese medicine composition provided by the invention is specifically classified for the apoplexy sequelae, starts from the functions in vivo, promotes blood circulation to remove blood stasis, searches for wind and dredges collaterals, and has good curative effect on relieving the apoplexy sequelae.
4. Patent application CN201210304469.5 discloses a traditional Chinese medicine composition for treating headache and dizziness caused by apoplexy sequela, which comprises the following traditional Chinese medicines in parts by weight: 5-15 of ground beetle, 5-25 of zaocys dhumnade, 5-25 of agkistrodon, 5-15 of scorpion, 5-25 of panax notoginseng, 10-30 of frankincense, 10-30 of myrrh, 10-30 of gastrodia elata, 10-30 of white muscardine silkworm and 15-45 of angelica sinensis. The traditional Chinese medicine composition can be used for treating headache and dizziness caused by apoplexy sequela, has quick response and small toxic and side effects, and can prevent apoplexy. The invention has curative effect on other cerebrovascular diseases, dizziness, headache, lumbago, skelalgia and the like, and can relieve arteriosclerosis, hyperlipidemia, coronary heart disease and various symptoms caused by osteoporosis.
However, the existing traditional Chinese medicines for relieving the sequela of the apoplexy basically need to be brewed and taken orally, are inconvenient to use, have poor curative effect, are easy to repeat after physical therapy, and cause great trouble to patients.
Disclosure of Invention
The invention provides a herbal moxibustion for relieving stroke sequelae and a preparation method thereof, aiming at solving the technical problems.
In order to achieve the above purpose, the invention adopts the following technical scheme:
a herbal moxibustion for relieving apoplexy sequela is prepared from the following raw materials in parts by weight: 250-300 parts of arisaema cum bile, 150-200 parts of concha haliotidis, 55-95 parts of gastrodia tuber powder, 125-165 parts of poria cocos, 60-100 parts of coptis chinensis, 60-100 parts of polygala tenuifolia, 60-100 parts of notopterygium root, 155-195 parts of uncaria, 155-195 parts of Chinese starjasmine stem, 155-195 parts of hemp seed oil, 155-195 parts of safflower carthamus, 80-120 parts of large-leaved gentian, 80-120 parts of radix clematidis, 165-205 parts of peach seed oil, 85-125 parts of old onion, 85-125 parts of fresh ginger, 135-175 parts of beautiful sweetgum fruit, 100-150 parts of deer sinew and 150-200 parts of musk.
Furthermore, the Baicao moxibustion for relieving apoplexy sequelae is prepared from the following raw materials in parts by weight: 260-290 parts of arisaema cum bile, 160-190 parts of concha haliotidis, 65-85 parts of gastrodia tuber powder, 135-155 parts of poria cocos, 70-90 parts of coptis chinensis, 70-90 parts of polygala tenuifolia, 70-90 parts of notopterygium root, 165-185 parts of uncaria, 165-185 parts of Chinese starjasmine stem, 165-185 parts of hemp seed oil, 165-185 parts of safflower carthamus, 90-110 parts of large-leaved gentian, 90-110 parts of radix clematidis, 175-195 parts of peach seed oil, 95-115 parts of old onion, 95-115 parts of fresh ginger, 145-165 parts of beautiful sweetgum fruit, 110-140 parts of deer sinew and 160-190 parts of musk.
Furthermore, the Baicao moxibustion for relieving apoplexy sequelae is prepared from the following raw materials in parts by weight: 275 parts of arisaema cum bile, 175 parts of abalone shell, 75 parts of gastrodia tuber powder, 145 parts of poria cocos, 80 parts of coptis chinensis, 80 parts of polygala tenuifolia, 80 parts of notopterygium root, 175 parts of uncaria, 175 parts of Chinese starjasmine stem, 175 parts of hemp seed oil, 175 parts of safflower, 100 parts of large-leaved gentian, 100 parts of radix clematidis, 185 parts of peach kernel oil, 105 parts of old onion, 105 parts of fresh ginger, 155 parts of beautiful sweetgum fruit, 125 parts of deer sinew and 175 parts of musk.
Further, the preparation method of the Baicao moxibustion for relieving the stroke sequelae comprises the following steps:
(1) weighing arisaema cum bile, concha haliotidis, poria cocos, coptis chinensis, polygala tenuifolia, notopterygium root, uncaria, Chinese starjasmine stem, safflower, large-leaved gentian, radix clematidis, old shallot, fresh ginger, beautiful sweetgum fruit, deer sinew and musk according to the weight parts, respectively sending the weighed materials into a dryer for drying treatment, uniformly mixing the materials, sending the materials into a crusher for crushing treatment, and uniformly stirring the materials to obtain a mixed material;
(2) adding the gastrodia elata powder, the hemp seed oil and the peach seed oil into the mixed powder obtained in the step (1), uniformly stirring, sprinkling water to enable the water content of the materials to be 15-20%, standing, drying, then putting into a pulverizer to be pulverized and sieved, and making into strips or columns in an extrusion or rolling mode to obtain the herbal moxibustion for relieving stroke sequelae.
Further, in the step (1), the material is crushed to have the granularity and the diameter of 6-8 mm.
Further, in the step (1), the drying treatment temperature is 70-75 ℃, the drying treatment time is 5-7 hours, the air humidity is controlled at 20-25%, and the drying is carried out until the water content of the material is 22-25%.
Further, in the steps (1) and (2), the rotating speed of stirring is 120-150 r/min, and the time is 80-100 s.
Further, in the step (2), the standing treatment is to place the material at normal temperature for 46-48 h.
Further, in the step (2), the sieving is performed by a sieve with 100-150 meshes.
Further, in the step (2), the drying treatment temperature is 43-46 ℃, the drying treatment time is 36-40 hours, the air humidity is controlled at 8-10%, and the drying is carried out until the water content of the material is lower than 8%.
Due to the adoption of the technical scheme, the invention has the following beneficial effects:
(1) the herbal moxibustion for relieving the stroke sequelae is mainly used for treating symptoms such as restlessness, night sleep restlessness, excessive and white phlegm, language disorder, yin deficiency and essence deficiency, constipation due to fu-organs, urinary incontinence, limb stiffness and pain, aphonia, deficiency of middle-jiao, yin deficiency, hemiplegia, foot swelling, high blood pressure and the like, has the effects of tonifying qi and activating blood, removing stasis and reducing phlegm, and tonifying spleen and dredging collaterals, has the characteristics of good curative effect, quick radical cure and the like, can treat both symptoms and root causes, can relieve the stroke sequelae, and can improve the immune function of a human body.
(2) The medicines provided by the invention are all natural plant traditional Chinese medicines, besides small side effect, the price is low, each medicine has uniqueness in form, nature and taste, channel tropism and functional indication, and arisaema cum bile, ligusticum wallichii, red paeony root, safflower, peach kernel and the like have the effects of activating blood and dissolving stasis; notopterygii rhizoma, herba Alii Fistulosi, rhizoma Zingiberis recens, and fructus Lipuidambaris etc. have effects of activating yang and promoting blood circulation; ligamentum Cervi, Moschus etc. have effects of inducing resuscitation and relieving obstruction. When in use, the medicine can be added or reduced freely according to different people, causes and the like to be flexibly applied so as to achieve the purpose of treating diseases.
Detailed Description
The following is a detailed description of the embodiments of the present invention, but the present invention is not limited to these embodiments, and any modifications or substitutions in the basic spirit of the embodiments are included in the scope of the present invention as claimed in the claims.
Example 1
A herbal moxibustion for relieving apoplexy sequela is prepared from the following raw materials in parts by weight: 250 parts of arisaema cum bile, 150 parts of concha haliotidis, 55 parts of gastrodia tuber powder, 125 parts of poria cocos, 60 parts of coptis chinensis, 60 parts of polygala tenuifolia, 60 parts of notopterygium root, 155 parts of uncaria, 155 parts of Chinese starjasmine stem, 155 parts of hemp seed oil, 155 parts of safflower, 80 parts of large-leaved gentian, 80 parts of radix clematidis, 165 parts of peach kernel oil, 85 parts of old onion, 85 parts of fresh ginger, 135 parts of beautiful sweetgum fruit, 100 parts of deer sinew and 150 parts of musk.
The preparation method of the Baicao moxibustion for relieving the stroke sequelae comprises the following steps:
(1) weighing arisaema cum bile, concha haliotidis, poria cocos, coptis chinensis, polygala tenuifolia, notopterygium root, uncaria, Chinese starjasmine stem, safflower, large-leaved gentian, radix clematidis, old shallot, fresh ginger, beautiful sweetgum fruit, deer sinew and musk according to the weight parts, respectively sending the weighed materials into a dryer for drying treatment, uniformly mixing the materials, sending the materials into a crusher for crushing treatment, and uniformly stirring the materials to obtain a mixed material;
the crushing is to crush the materials to the particle size of 6 mm; the drying treatment temperature is 70 ℃, the drying treatment time is 5 hours, the air humidity is controlled to be 20%, and the drying is carried out until the water content of the material is 22%;
(2) adding gastrodia elata powder, hemp seed oil and peach kernel oil into the mixed powder obtained in the step (1), uniformly stirring, sprinkling water to enable the water content of the materials to be 15-20%, standing, drying, then putting into a pulverizer to be pulverized and sieved, and making into strips or columns in an extrusion or rolling mode to obtain the herbal moxibustion for relieving stroke sequelae;
the standing treatment is to place the materials at normal temperature for 46 hours; the sieving is to pass through a 100-mesh screen; the drying treatment temperature is 43 ℃, the drying treatment time is 36h, the air humidity is controlled at 8%, and the drying is carried out until the water content of the materials is lower than 8%.
Further, in the steps (1) and (2), the rotating speed of the stirring is 120r/min, and the time is 80 s.
Example 2
A herbal moxibustion for relieving apoplexy sequela is prepared from the following raw materials in parts by weight: 300 parts of arisaema cum bile, 200 parts of concha haliotidis, 95 parts of gastrodia tuber powder, 165 parts of poria cocos, 100 parts of coptis chinensis, 100 parts of polygala tenuifolia, 100 parts of notopterygium root, 195 parts of uncaria, 195 parts of Chinese starjasmine stem, 195 parts of hemp seed oil, 195 parts of safflower, 120 parts of large-leaved gentian, 120 parts of radix clematidis, 205 parts of peach kernel oil, 125 parts of old onion, 125 parts of fresh ginger, 175 parts of beautiful sweetgum fruit, 150 parts of deer sinew and 200 parts of musk.
The preparation method of the Baicao moxibustion for relieving the stroke sequelae comprises the following steps:
(1) weighing arisaema cum bile, concha haliotidis, poria cocos, coptis chinensis, polygala tenuifolia, notopterygium root, uncaria, Chinese starjasmine stem, safflower, large-leaved gentian, radix clematidis, old shallot, fresh ginger, beautiful sweetgum fruit, deer sinew and musk according to the weight parts, respectively sending the weighed materials into a dryer for drying treatment, uniformly mixing the materials, sending the materials into a crusher for crushing treatment, and uniformly stirring the materials to obtain a mixed material;
the crushing is to crush the materials to 8mm in particle size and diameter; the drying treatment temperature is 75 ℃, the drying treatment time is 7 hours, the air humidity is controlled to be 25%, and the drying is carried out until the water content of the material is 25%;
(2) adding rhizoma Gastrodiae powder, fructus Cannabis oil, and oleum Persicae into the mixed powder of step (1), stirring, sprinkling water to make water content of the material 20%, standing, drying, pulverizing in a pulverizer, sieving, and making into strip or column by extrusion or rolling to obtain BAICAO moxibustion for relieving apoplexy sequela;
the standing treatment is to place the materials at normal temperature for 48 hours; the sieving is to pass through a 150-mesh screen; the drying treatment temperature is 46 ℃, the drying treatment time is 40h, the air humidity is controlled at 10%, and the drying is carried out until the water content of the materials is lower than 8%.
Further, in the steps (1) and (2), the rotating speed of the stirring is 150r/min, and the time is 100 s.
Example 3
A herbal moxibustion for relieving apoplexy sequela is prepared from the following raw materials in parts by weight: 260 parts of arisaema cum bile, 160 parts of concha haliotidis, 65 parts of gastrodia tuber powder, 135 parts of poria cocos, 70 parts of coptis chinensis, 70 parts of polygala tenuifolia, 70 parts of notopterygium root, 165 parts of uncaria, 165 parts of Chinese starjasmine stem, 165 parts of hemp seed oil, 165 parts of safflower, 90 parts of large-leaved gentian, 90 parts of radix clematidis, 175 parts of peach kernel oil, 95 parts of old onion, 95 parts of fresh ginger, 145 parts of beautiful sweetgum fruit, 110 parts of deer sinew and 160 parts of musk.
The preparation method of the Baicao moxibustion for relieving the stroke sequelae comprises the following steps:
(1) weighing arisaema cum bile, concha haliotidis, poria cocos, coptis chinensis, polygala tenuifolia, notopterygium root, uncaria, Chinese starjasmine stem, safflower, large-leaved gentian, radix clematidis, old shallot, fresh ginger, beautiful sweetgum fruit, deer sinew and musk according to the weight parts, respectively sending the weighed materials into a dryer for drying treatment, uniformly mixing the materials, sending the materials into a crusher for crushing treatment, and uniformly stirring the materials to obtain a mixed material;
the crushing is to crush the materials to the particle size of 6.5 mm; the drying treatment is carried out at the temperature of 71 ℃ for 5.5h, the air humidity is controlled at 21%, and the drying is carried out until the water content of the material is 23%;
(2) adding rhizoma Gastrodiae powder, fructus Cannabis oil, and oleum Persicae into the mixed powder of step (1), stirring, sprinkling water to make water content of the material to 16%, standing, drying, pulverizing in a pulverizer, sieving, and making into strip or column by extrusion or rolling to obtain BAICAO moxibustion for relieving apoplexy sequela;
the standing treatment is to place the materials at normal temperature for 46.5 hours; the sieving is to pass through a 110-mesh sieve; the drying treatment temperature is 44 ℃, the drying treatment time is 37 hours, the air humidity is controlled to be 8.5%, and the drying is carried out until the water content of the materials is lower than 8%.
Further, in the steps (1) and (2), the rotating speed of the stirring is 130r/min, and the time is 85 s.
Example 4
A herbal moxibustion for relieving apoplexy sequela is prepared from the following raw materials in parts by weight: 290 parts of arisaema cum bile, 190 parts of concha haliotidis, 85 parts of gastrodia tuber powder, 155 parts of poria cocos, 90 parts of coptis chinensis, 90 parts of polygala tenuifolia, 90 parts of notopterygium root, 185 parts of uncaria, 185 parts of Chinese starjasmine stem, 185 parts of hemp seed oil, 185 parts of safflower, 110 parts of large-leaved gentian, 110 parts of radix clematidis, 195 parts of peach kernel oil, 115 parts of old onion, 115 parts of fresh ginger, 165 parts of beautiful sweetgum fruit, 140 parts of deer sinew and 190 parts of musk.
The preparation method of the Baicao moxibustion for relieving the stroke sequelae comprises the following steps:
(1) weighing arisaema cum bile, concha haliotidis, poria cocos, coptis chinensis, polygala tenuifolia, notopterygium root, uncaria, Chinese starjasmine stem, safflower, large-leaved gentian, radix clematidis, old shallot, fresh ginger, beautiful sweetgum fruit, deer sinew and musk according to the weight parts, respectively sending the weighed materials into a dryer for drying treatment, uniformly mixing the materials, sending the materials into a crusher for crushing treatment, and uniformly stirring the materials to obtain a mixed material;
the crushing is to crush the materials to the granularity of 7.5mm in diameter; the drying treatment temperature is 74 ℃, the drying treatment time is 6.5 hours, the air humidity is controlled at 24%, and the drying is carried out until the water content of the material is 24%;
(2) adding rhizoma Gastrodiae powder, fructus Cannabis oil, and oleum Persicae into the mixed powder of step (1), stirring, sprinkling water to make water content of the material 19%, standing, drying, pulverizing in a pulverizer, sieving, and making into strip or column by extrusion or rolling to obtain BAICAO moxibustion for relieving apoplexy sequela;
the standing treatment is to place the materials at normal temperature for 47.5 hours; the sieving is to pass through a 140-mesh screen; the drying treatment temperature is 45 ℃, the drying treatment time is 39 hours, the air humidity is controlled at 9.5%, and the drying is carried out until the water content of the materials is lower than 8%.
Further, in the steps (1) and (2), the rotating speed of the stirring is 140r/min, and the time is 95 s.
Example 5
A herbal moxibustion for relieving apoplexy sequela is prepared from the following raw materials in parts by weight: 275 parts of arisaema cum bile, 175 parts of abalone shell, 75 parts of gastrodia tuber powder, 145 parts of poria cocos, 80 parts of coptis chinensis, 80 parts of polygala tenuifolia, 80 parts of notopterygium root, 175 parts of uncaria, 175 parts of Chinese starjasmine stem, 175 parts of hemp seed oil, 175 parts of safflower, 100 parts of large-leaved gentian, 100 parts of radix clematidis, 185 parts of peach kernel oil, 105 parts of old onion, 105 parts of fresh ginger, 155 parts of beautiful sweetgum fruit, 125 parts of deer sinew and 175 parts of musk.
The preparation method of the Baicao moxibustion for relieving the stroke sequelae comprises the following steps:
(1) weighing arisaema cum bile, concha haliotidis, poria cocos, coptis chinensis, polygala tenuifolia, notopterygium root, uncaria, Chinese starjasmine stem, safflower, large-leaved gentian, radix clematidis, old shallot, fresh ginger, beautiful sweetgum fruit, deer sinew and musk according to the weight parts, respectively sending the weighed materials into a dryer for drying treatment, uniformly mixing the materials, sending the materials into a crusher for crushing treatment, and uniformly stirring the materials to obtain a mixed material;
the crushing is to crush the materials to the particle size of 7 mm; the drying treatment temperature is 72 ℃, the drying treatment time is 6 hours, the air humidity is controlled at 23%, and the drying is carried out until the water content of the material is 23.5%;
(2) adding rhizoma Gastrodiae powder, fructus Cannabis oil, and oleum Persicae into the mixed powder of step (1), stirring, sprinkling water to make water content of the material 18%, standing, drying, pulverizing in a pulverizer, sieving, and making into strip or column by extrusion or rolling to obtain BAICAO moxibustion for relieving apoplexy sequela;
the standing treatment is to place the materials at normal temperature for 47 hours; the sieving is to pass through a 130-mesh screen; the drying treatment temperature is 45 ℃, the drying treatment time is 38h, the air humidity is controlled at 9%, and the drying is carried out until the water content of the materials is lower than 8%.
Further, in the steps (1) and (2), the rotating speed of the stirring is 135r/min, and the time is 90 s.
Comparative example 1
The preparation of the moxibustion stick or column was carried out according to the examples of the patent application cn201711132333. x.
Comparative example 2
The preparation of the moxibustion stick or column was carried out according to the example of CN201510949478.3 in the patent application.
Comparative example 3
The preparation of the moxibustion stick or column was carried out according to the example of CN201510803364.8 in the patent application.
Comparative example 4
The preparation of the moxibustion stick or column was carried out according to the example of CN201210304469.5 in the patent application.
To further illustrate that the present invention can achieve the technical effects, the following experiments were performed:
100 volunteers with the stroke sequelae are selected and randomly divided into 10 groups, the proportion of each group is equal, wherein 1 group is used as a blank control group, namely no moxibustion is carried out, and the other 9 groups are respectively used for auxiliary conditioning treatment of the volunteers with the stroke sequelae by adopting the moxibustion sticks or moxibustion columns prepared by the methods of examples 1-5 and comparative examples 1-4 for 60 days. The using method comprises the following steps: the suction moxibustion is ignited, the patient sucks a moxibustion strip or a moxibustion column like a smoker to achieve the treatment effect, each person sucks moxibustion 6-8 times every day, 1 branch is taken every time, and 15 days is a treatment course. The volunteers of each group were observed for their stroke sequelae.
Experimental results show that after 60 days of treatment, the volunteers who adopt the moxibustion sticks or moxibustion columns prepared in the embodiments 1-5 basically relieve apoplexy sequelae after 15 days of moxibustion, and gradually get better of various uncomfortable symptoms; the volunteers who adopt the moxibustion stick or the moxibustion column prepared in the comparative examples 1-4 for moxibustion have the stroke sequelae relieved after 25d of moxibustion and 29d of moxibustion, but have no improvement on discomfort symptoms of various stroke sequelae; while the blank had no improvement on stroke sequelae.
Experiments show that the herbal moxibustion prepared by the method has the effects of helping patients with stroke sequelae to improve various uncomfortable symptoms, has the effects of tonifying qi and activating blood, removing blood stasis and reducing phlegm, and tonifying spleen and dredging collaterals, and has the characteristics of good curative effect, quick radical cure and the like.
In summary, the herbal moxibustion for relieving the stroke sequelae is mainly used for treating symptoms such as restlessness, insomnia, excessive and white phlegm, language disorder, yin deficiency and essence deficiency, constipation due to fu-organs, urinary incontinence, limb stiffness and pain, aphonia, deficiency of middle-jiao, yin deficiency, hemiplegia, foot swelling, high blood pressure and the like, has the effects of tonifying qi and activating blood, removing blood stasis and reducing phlegm, and invigorating spleen and dredging collaterals, has the characteristics of good curative effect, quick radical cure and the like, and is convenient to use only by inhaling like smoking.
It will be evident to those skilled in the art that the invention is not limited to the details of the foregoing illustrative embodiments, and that the present invention may be embodied in other specific forms without departing from the spirit or essential attributes thereof. The present embodiments are therefore to be considered in all respects as illustrative and not restrictive, the scope of the invention being indicated by the appended claims rather than by the foregoing description, and all changes which come within the meaning and range of equivalency of the claims are therefore intended to be embraced therein.
Claims (10)
1. The herbal moxibustion for relieving stroke sequelae is characterized by being prepared from the following raw materials in parts by weight: 250-300 parts of arisaema cum bile, 150-200 parts of concha haliotidis, 55-95 parts of gastrodia tuber powder, 125-165 parts of poria cocos, 60-100 parts of coptis chinensis, 60-100 parts of polygala tenuifolia, 60-100 parts of notopterygium root, 155-195 parts of uncaria, 155-195 parts of Chinese starjasmine stem, 155-195 parts of hemp seed oil, 155-195 parts of safflower carthamus, 80-120 parts of large-leaved gentian, 80-120 parts of radix clematidis, 165-205 parts of peach seed oil, 85-125 parts of old onion, 85-125 parts of fresh ginger, 135-175 parts of beautiful sweetgum fruit, 100-150 parts of deer sinew and 150-200 parts of musk.
2. The Baicao moxibustion for relieving sequela of apoplexy according to claim 1, which is prepared from the following raw materials in parts by weight: 260-290 parts of arisaema cum bile, 160-190 parts of concha haliotidis, 65-85 parts of gastrodia tuber powder, 135-155 parts of poria cocos, 70-90 parts of coptis chinensis, 70-90 parts of polygala tenuifolia, 70-90 parts of notopterygium root, 165-185 parts of uncaria, 165-185 parts of Chinese starjasmine stem, 165-185 parts of hemp seed oil, 165-185 parts of safflower carthamus, 90-110 parts of large-leaved gentian, 90-110 parts of radix clematidis, 175-195 parts of peach seed oil, 95-115 parts of old onion, 95-115 parts of fresh ginger, 145-165 parts of beautiful sweetgum fruit, 110-140 parts of deer sinew and 160-190 parts of musk.
3. The Baicao moxibustion for relieving sequela of apoplexy according to claim 1, which is prepared from the following raw materials in parts by weight: 275 parts of arisaema cum bile, 175 parts of abalone shell, 75 parts of gastrodia tuber powder, 145 parts of poria cocos, 80 parts of coptis chinensis, 80 parts of polygala tenuifolia, 80 parts of notopterygium root, 175 parts of uncaria, 175 parts of Chinese starjasmine stem, 175 parts of hemp seed oil, 175 parts of safflower, 100 parts of large-leaved gentian, 100 parts of radix clematidis, 185 parts of peach kernel oil, 105 parts of old onion, 105 parts of fresh ginger, 155 parts of beautiful sweetgum fruit, 125 parts of deer sinew and 175 parts of musk.
4. The preparation method of the Baicao moxibustion for relieving stroke sequelae as claimed in any one of claims 1 to 3, which is characterized by comprising the following steps:
(1) weighing arisaema cum bile, concha haliotidis, poria cocos, coptis chinensis, polygala tenuifolia, notopterygium root, uncaria, Chinese starjasmine stem, safflower, large-leaved gentian, radix clematidis, old shallot, fresh ginger, beautiful sweetgum fruit, deer sinew and musk according to the weight parts, respectively sending the weighed materials into a dryer for drying treatment, uniformly mixing the materials, sending the materials into a crusher for crushing treatment, and uniformly stirring the materials to obtain a mixed material;
(2) adding the gastrodia elata powder, the hemp seed oil and the peach seed oil into the mixed powder obtained in the step (1), uniformly stirring, sprinkling water to enable the water content of the materials to be 15-20%, standing, drying, then putting into a pulverizer to be pulverized and sieved, and making into strips or columns in an extrusion or rolling mode to obtain the herbal moxibustion for relieving stroke sequelae.
5. The preparation method of Baicao moxibustion for relieving apoplexy sequelae as claimed in claim 4, wherein the preparation method comprises the following steps: in the step (1), the material is crushed to have the granularity and the diameter of 6-8 mm.
6. The preparation method of Baicao moxibustion for relieving apoplexy sequelae as claimed in claim 4, wherein the preparation method comprises the following steps: in the step (1), the drying treatment is carried out at the temperature of 70-75 ℃ for 5-7 h, the air humidity is controlled at 20-25%, and the drying is carried out until the water content of the material is 22-25%.
7. The preparation method of Baicao moxibustion for relieving apoplexy sequelae as claimed in claim 4, wherein the preparation method comprises the following steps: in the steps (1) and (2), the rotating speed of stirring is 120-150 r/min, and the time is 80-100 s.
8. The preparation method of Baicao moxibustion for relieving apoplexy sequelae as claimed in claim 4, wherein the preparation method comprises the following steps: in the step (2), the standing treatment is to place the material at normal temperature for 46-48 h.
9. The preparation method of Baicao moxibustion for relieving apoplexy sequelae as claimed in claim 4, wherein the preparation method comprises the following steps: in the step (2), the sieving is performed by a sieve of 100-150 meshes.
10. The preparation method of Baicao moxibustion for relieving apoplexy sequelae as claimed in claim 4, wherein the preparation method comprises the following steps: in the step (2), the temperature of the drying treatment is 43-46 ℃, the time is 36-40 hours, the air humidity is controlled at 8-10%, and the drying is carried out until the water content of the material is lower than 8%.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011418153.XA CN112316101A (en) | 2020-12-07 | 2020-12-07 | Baicao suction moxibustion for relieving stroke sequela and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011418153.XA CN112316101A (en) | 2020-12-07 | 2020-12-07 | Baicao suction moxibustion for relieving stroke sequela and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN112316101A true CN112316101A (en) | 2021-02-05 |
Family
ID=74301655
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202011418153.XA Pending CN112316101A (en) | 2020-12-07 | 2020-12-07 | Baicao suction moxibustion for relieving stroke sequela and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112316101A (en) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1073103A (en) * | 1992-12-11 | 1993-06-16 | 唐山市龙山制药厂 | Prescription of Xueshuankang capsule and its preparation technology |
| CN1085442A (en) * | 1993-07-27 | 1994-04-20 | 李嘉宾 | The medicine of a kind of prevention, treatment apoplexy |
| CN101411852A (en) * | 2008-11-21 | 2009-04-22 | 汝州市中医院 | Capsule containing hooked uncaria and gastrodia |
| CN110124006A (en) * | 2019-07-02 | 2019-08-16 | 李大为 | Hundred hay-scented moxibustions and its manufacture craft |
-
2020
- 2020-12-07 CN CN202011418153.XA patent/CN112316101A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1073103A (en) * | 1992-12-11 | 1993-06-16 | 唐山市龙山制药厂 | Prescription of Xueshuankang capsule and its preparation technology |
| CN1085442A (en) * | 1993-07-27 | 1994-04-20 | 李嘉宾 | The medicine of a kind of prevention, treatment apoplexy |
| CN101411852A (en) * | 2008-11-21 | 2009-04-22 | 汝州市中医院 | Capsule containing hooked uncaria and gastrodia |
| CN110124006A (en) * | 2019-07-02 | 2019-08-16 | 李大为 | Hundred hay-scented moxibustions and its manufacture craft |
Non-Patent Citations (3)
| Title |
|---|
| 崔俊波等: "活血法治疗缺血性中风的临床研究进展", 《陕西中医》 * |
| 钟琼仙: "通窍活血汤加减治疗中风(中经络)69例观察", 《云南中医中药杂志》 * |
| 顾绍瑜: "加减解语丹治疗中风不语30例临床观察", 《中医临床研究》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104013868B (en) | Traditional Chinese medicine composition for treating chronic obstructive pulmonary disease and preparation method thereof | |
| CN113786459A (en) | Pharmaceutical composition for treating cardiovascular and cerebrovascular diseases, and preparation method and application thereof | |
| CN108478767A (en) | Plaster for treating joint swelling and pain | |
| CN101181444B (en) | Multi-efficacy externally used drug as well as method for preparing immersion agent thereof | |
| CN112316101A (en) | Baicao suction moxibustion for relieving stroke sequela and preparation method thereof | |
| CN103385941A (en) | Chinese herbal medicine pain-relieving medicinal moxibustion | |
| CN109908209A (en) | A kind of pharmaceutical composition and its preparation method and application for treating allergic rhinitis | |
| CN114522213A (en) | Herbal atomized composition for improving memory and preparation method thereof | |
| CN103751708A (en) | Traditional Chinese medicine external preparation for treating varix of lower limb and preparation method thereof | |
| CN113082191A (en) | Preparation for effectively treating myocardial infarction hemiplegia and preparation method thereof | |
| CN110613793A (en) | Anti-tumor composition and preparation method and application thereof | |
| CN104623381A (en) | Traditional-Chinese-medicine composition for treating skin disease caused by blood heat and liver depression | |
| CN110974894A (en) | Traditional Chinese medicine composition for treating diabetes combined with cerebral infarction | |
| CN109908246A (en) | The external application Chinese medicine formula for treating lumbar pain orthopaedic disease | |
| CN115554356B (en) | Traditional Chinese medicine composition, plaster containing traditional Chinese medicine composition and preparation method of plaster | |
| CN109620944B (en) | A Chinese medicinal composition with effects of dispelling pathogenic wind, removing dampness, strengthening tendons and bones, and its preparation method | |
| CN107595998B (en) | Traditional Chinese medicine composition for stroke convalescence and preparation method thereof | |
| CN105770081A (en) | Composition preparation used for promoting healing after cerebral hemorrhage operation and preparation method thereof | |
| CN115645488A (en) | Rhinitis medicine | |
| CN115068572A (en) | Traditional Chinese medicine preparation for treating rheumatic valvular heart disease and preparation method thereof | |
| CN114028473A (en) | A Chinese medicated liquor for treating traumatic injury, and its preparation method | |
| CN113274468A (en) | A pharmaceutical composition for the treatment of tuberculosis of bone, joint and spine | |
| CN116531443A (en) | Method for producing ointment for treating skin disease | |
| CN112675247A (en) | Herbal medicinal liquor for treating neck, shoulder, waist and leg pain | |
| CN114470128A (en) | Herbal atomized composition for promoting intelligence and refreshing brain and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210205 |